Asset 2 Conferences
10 year VIB Conferences

New Horizons in Neurodegeneration

9-10 October 2025, Leuven, Belgium
Organized in partnership with Cell Press
NHND-CampaignImage-Test2

New Horizons in Neurodegeneration

New Horizons in Neurodegeneration

Organized in partnership with Cell Press

Keep me postedAdd to calendar

Cell Press

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS) manifest with distinct clinical features but shares underlying mechanisms. Understanding neurodegenerative diseases is critical in the quest to develop preventive measures, diagnostic tools, and targeted therapies.

This conference brings together leading scientists in the field to share groundbreaking research, novel methodologies, and cutting-edge technologies, all aimed at unraveling the complexities of neurodegeneration.

The presentations and discussions will focus on:

  • Development of new models to study neurodegeneration
  • New technologies to study neurodegeneration
  • Role of Neuro-inflammation in neurodegeneration
  • Novel therapeutics for neurodegenerative diseases

This conference with a somewhat larger scale and scope is at the same time a celebration for 10 years of VIB conferences and is organized in partnership with Cell Press.

Abstracts & travel grants
Submit your abstract for a poster presentation before the deadline of 4 September 2025.
We offer four travel grants to international junior scientists, which will reimburse travel costs up to €400. The deadline to participate was 1 July 2025.

Host City: Leuven
Want to know more about the host city of this conference? Find out where the best restaurants, bars, or last-minute print shops are. Check the city page here.

Share

Confirmed speakers

Li Gan
Gan Li - VIB Training & Conferences - Speaker picture
Li Gan

Li Gan

Cornell Medicine, Appel Alzheimer’s Disease Research Institute, US
Selina Wray
Selina Wray - VIB Conferences - Speaker picture
Selina Wray

Selina Wray

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, UK

Program

Day 1 - Thursday, 09 October, 2025

08:20
08:50
Welcome coffee & registration
08:50
09:00
Welcome words
09:00
12:35
Session 1: Development of new models to study neurodegeneration
09:00
09:30
Innate immunity and neurodegeneration: challenges and opportunities

Li Gan

Cornell Medicine, Appel Alzheimer’s Disease Research Institute, US
09:30
10:00
Understanding molecular heterogeneity of Alzheimer’s disease using personalised stem cell models

Selina Wray

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, UK
10:00
10:30
Impact of genetics in the biology of microglia in dementia
10:30
10:45
A long-term human brain organoid model to unravel human developmental features and early Alzheimer's disease hallmarks

Ira Espuny-Camacho

GIGA-Neuroscience Department, GIGA Institute, University of Liège, BE
Selected from abstracts
10:45
11:15
Coffee break
11:15
11:45
Applying iPSC-organoids to profiling the impact of 4R tau on mitochondrial health and microtubule stability
11:45
12:15
Modelling neurodegenerative diseases in a dish
12:15
12:30
Genetic heterogeneity alters the amyloid-beta response of human microglia

Annerieke Sierksma

Department of Neurosciences and Leuven Brain Institute, KU Leuven, BE; VIB-KU Leuven Center for Neuroscience, BE
Selected from abstracts
12:30
12:35
End-to-End Solutions for Neurodegeneration Research

Benjamin Versier

Territory Manager, VectorBuilder, FR
Sponsored talk
12:35
13:30
Lunch
13:30
14:30
Poster session 1
14:30
18:00
Session 2: New developments in neurodegeneration
14:30
15:00
Prospects for improved neuroprotection in ALS/MND

Pamela Shaw

Sheffield Institute for Translational Neuroscience, UK
15:00
15:30
Defining Proteins in Health and Disease

Judith Steen

Harvard Medical School & Boston Children's Hospital, US
15:30
16:00
Characterization of genetic variation in transcriptional enhancers in the cingulate gyrus and substantia nigra
16:00
16:15
Dissecting the role of skeletal muscle in TDP-43- and FUS-associated ALS

Hannah Walgrave

Radboud University, NL
Selected from abstracts
16:15
16:45
Coffee break
16:45
17:00
How heterotypic interactions modulate amyloid formation
Selected from abstracts
17:00
17:30
Critical Inflection Points in the Progression of Alzheimer’s Disease

Bart De Strooper

VIB-KU Leuven Center For Neuroscience, BE & UK Dementia Research Institute, UK
17:30
18:00
TDP-43 mislocalization in neurodegeneration initiated by CREBBP acetylation of lysine 82 in its nuclear localization sequence
18:00
19:00
Reception
19:00
20:00
Social activity
20:00
22:30
Conference dinner

Additional fee

Day 2 - Friday, 10 October, 2025

08:30
09:00
Welcome coffee
09:00
11:15
Session 3: Role of neuro-inflammation in neurodegeneration
09:00
09:30
Brain-immune communications in Alzheimer’s disease
09:30
10:00
Gut-Brain Neuroimmune Axis in Neurodegenerative Disease
10:00
10:30
Neurovascular Interactions: From mechanisms to clinical trials
10:30
10:45
The Alzheimer’s therapeutic Lecanemab induces an amyloid-clearing program in microglia

Giulia Albertini

VIB-KU Leuven Centre for Brain and Disease Research, BE; Department of Neurosciences and Leuven Brain Institute, KU Leuven, BE
Selected from abstracts
10:45
11:15
Coffee break
11:15
12:35
Session 4: Genetic modifiers in neurodegenerative diseases
11:45
12:15
The genomic spectrum of repeat expansion loci and their growing associations to disease
12:15
12:30
Investigating Low-Frequency Somatic Single Nucleotide Variants in Multiple System Atrophy Brains

Ben Thompson

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, GB; Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, US
Selected from abstracts
12:30
12:35
Unlocking the Human Brain secrets with BD Rhapsody™ Single-Cell Multiomics System

Stefano Bonelli

BD Biosciences Benelux, BE
Sponsored talk
12:35
13:30
Lunch
13:30
14:30
Poster session 2
14:30
18:00
Session 5: Novel therapeutics for neurodegenerative diseases
14:30
15:00
Resilience to cognitive decline to escape dementia: what we can learn from cognitively healthy centenarians

Henne Holstege

VIB-KU Leuven Center For Neuroscience, BE & Amsterdam University Medical Center, NL
15:00
15:30
Transcription factor regulation of microglial states and their link to Alzheimer’s disease genetics
15:30
16:00
An Oligonucleotide Transport Vehicle for the Treatment of Alzheimer's Disease
16:00
16:15
Multimodal polytherapy for ALS targeting both ends of the motor unit

Peter Crouch

The University of Melbourne, AU
Selected from abstracts
16:15
16:45
Coffee break
16:45
17:00
Lowering the Htt1a transcript as an effective therapy for Huntington’s disease

Aikaterini Papadopoulou

University College London, GB
Selected from abstracts
17:00
17:30
Probe neurodegeneration mechanisms by targeted degradation of lipid droplets
17:30
18:00
Motor neuron degeneration driven by TRPV4 mediated breakdown of blood-neural barriers
18:00
18:10
Closing words

Organizing committee

Abstracts

Poster information
The format for your poster should be: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation. All accepted poster submissions will have a chance to win the Cell Press Poster Prize!

The full list of abstracts will be available on 23-09-2025 until 10-01-2026
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 23-09-2025 until 10-01-2026
This list will only be available for registered attendees of the event.